Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nectar Allergy logo — Freedom over allergies

Nectar Allergy

Freedom over allergies

Founded 2021 20 employees Series A Total: $24.50M Health Care, Health and Wellness +1

General Information

Company Name Nectar Allergy
Founded Year 2021
Employees 20
Industries Health Care, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Nectar Allergy. To contact Nectar Allergy, visit mynectar.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Nectar Allergy

Nectar Allergy is a health tech startup with the slogan "Freedom over allergies." Founded in 2021, the company aims to revolutionize allergy care by directly connecting individuals with physicians and pharmacists to create personalized treatment plans addressing the root cause of allergies. Their ultimate goal is to eliminate allergy-related disruptions from people's lives. The company operates in the Health Care, Health and Wellness, and Pharmaceutical industries. Their latest milestone is a remarkable $16.50M Series A investment received on 20 December 2022. The investment came from prominent firms including Obvious Ventures, Harmony Partners, and Juxtapose. This recent funding serves as a testament to the potential and significance of Nectar Allergy's offerings, positioning them for further growth and development in the health tech sector.

Taxonomy: allergy care, physician, pharmacist, treatment plans, customized, revolutionary, allergies, personalized medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $16.50M 3
Obvious Ventures Harmony Partners Juxtapose
Obvious Ventures, Harmony Partners +1
20 Dec 2022
Seed Round $8.00M 2
Obvious Ventures Juxtapose
Obvious Ventures, Juxtapose
16 Mar 2022

Nectar Allergy Alternatives & Competitors

View All Alternatives
Nectar Allergy vs
Aspire Allergy & Sinus
Aspire Allergy & Sinus United States

Simple Relief. Better Life.

Private Equity
197 employees
Health Care, Health and Wellness
Nectar Allergy vs
Intrommune Therapeutics
Intrommune Therapeutics United States

Dedicated to developing safe and effective options for peanut and other food allergies

Series B
17 employees
Biotechnology, Health Care
Nectar Allergy vs
Wyndly (YC W21)
Wyndly (YC W21) United States

Life's better without allergies

Seed
10 employees
Health Care, Health and Wellness
View all alternatives

FAQ About Nectar Allergy

Freedom over allergies
Nectar Allergy was founded in 2021.
Nectar Allergy operates in Health Care, Health and Wellness and Pharmaceutical. Its work centres on allergy care, physician, pharmacist and treatment plans.
Nectar Allergy has approximately 20 employees.
Nectar Allergy has completed 2 funding rounds, raising a total of $24.50M. The latest funding stage is Series A.
Top alternatives and competitors to Nectar Allergy include Aspire Allergy & Sinus, Intrommune Therapeutics, Wyndly (YC W21), Allermi, ELANZA Wellness (Techstars NYC). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nectar Allergy and Aspire Allergy & Sinus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nectar Allergy, https://bouncewatch.com/company/nectar-allergy, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes